Browse: Departments   Dates   Agencies  

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

NOTICE: NOTICES

ACTION: Meetings:

DOCUMENT ACTION: Notice.

SUBJECT CATEGORY: Advisory Committee Information Hotline

DOCUMENT SUMMARY: The Food and Drug Administration (FDA) is announcing that we have revised the Advisory Committee Information Hotline (the hotline). The hotline provides the public with access to the most current information available on FDA advisory committee meetings. This notice supersedes all previously published announcements of FDA's Advisory Committee Information Hotline.

SUMMARY: Advisory Committee Information Hotline,

SUPPLEMENTAL INFORMATION

The Advisory Committee Information Hotline can be accessed by dialing 18007418138 or 3014430572. The advisory committee meeting information and information updates can also be accessed via FDA's Advisory Committee calendar at http://www.fda.gov/oc/advisory/accalendar/accalendar.html .

Each advisory committee is assigned a 10digit number. This 10 digit number will appear in each individual notice of meeting. The public can obtain information about a particular advisory committee meeting by using the committee's 10digit number. Information on the hotline is preliminary and may change before a meeting is actually held. The hotline will be updated when such changes are made. The following is a list of each advisory committee's 10digit number to be used when accessing the hotline.
ADVISORY COMMITTEE NUMBER OFFICE OF THE COMMISSIONER.............................................. Science Board to the FDA................... 3014512603
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH............................ Allergenic Products Advisory Committee..... 3014512388
Biological Response Modifiers Advisory 3014512389
Committee.
Blood Products Advisory Committee.......... 3014519516
Transmissible Spongiform Encephalopathies 3014512392
Advisory Committee.
Vaccines and Related Biological Products 3014512391
Advisory Committee.
CENTER FOR DRUG EVALUATION AND RESEARCH................................. Anesthetic and Life Support Drugs Advisory 3014512529
Committee.
AntiInfective Drugs Advisory Committee 3014512530
(Peds SubC).
Antiviral Drugs Advisory Committee......... 3014512531
Arthritis Advisory Committee............... 3014512532
Cardiovascular and Renal Drugs Advisory 3014512533
Committee.
[[Page 70513]]
Dermatologic and Ophthalmic Drugs Advisory 3014512534
Committee.
Drug Safety and Risk Management Advisory 3014512535
Committee (Drug Abuse Subcommittee).
Endocrinologic and Metabolic Drugs Advisory 3014512536
Committee.
Gastrointestinal Drugs Advisory Committee.. 3014512538
Nonprescription Drugs Advisory Committee... 3014512541
Oncologic Drugs Advisory Committee......... 3014512542
Peripheral and Central Nervous System Drugs 3014512543
Advisory Committee.
Pharmaceutical Science, Advisory Committee 3014512539
for.
Psychopharmacologic Drugs Advisory 3014512544
Committee.
PulmonaryAllergy Drugs Advisory Committee. 3014512545
Reproductive Health Drugs, Advisory 3014512537
Committee for.
CENTER FOR FOOD SAFETY AND APPLIED NUTRITION............................ Food Advisory Committee (full committee and 3014510564

subcommittees).

Additives and Ingredients Subcommittee .........................

Biotechnology Subcommittee...............

Contaminants and Natural Toxicants
Subcommittee.

Dietary Supplements Subcommittee.........

Infant Formula Subcommittee..............

Nutrition Subcommittee...................
CENTER FOR DEVICES AND RADIOLOGICAL HEALTH.............................. Device Good Manufacturing Practice Advisory 3014512398
Committee.
Medical Devices Advisory Committee N/A

(comprised of 18 panels).

Anesthesiology and Respiratory Therapy 3014512624 Devices Panel.

Circulatory System Devices Panel......... 3014512625

Clinical Chemistry and Clinical 3014512514 Toxicology Devices Panel.

Dental Products Panel.................... 3014512518

Ear, Nose, and Throat Devices Panel...... 3014512522

GastroenterologyUrology Devices Panel... 3014512523

General and Plastic Surgery Devices Panel 3014512519

General Hospital and Personal Use Devices 3014512520 Panel.

Hematology and Pathology Devices Panel... 3014512515

Immunology Devices Panel................. 3014512516

Medical Devices Dispute Resolution Panel. 3014510232

Microbiology Devices Panel............... 3014512517

Molecular and Clinical Genetics Panel.... 3014510231

Neurological Devices Panel............... 3014512513

ObstetricsGynecology Devices............ 3014512524

Ophthalmic Devices Panel................. 3014512396

Orthopaedic and Rehabilitation Devices 3014512521 Panel.

Radiological Devices Panel............... 3014512526 National Mammography Quality Assurance 3014512397
Advisory Committee.
Technical Electronic Product Radiation 3014512399
Safety Standards Committee.
CENTER FOR VETERINARY MEDICINE.......................................... Veterinary Medicine Advisory Committee..... 3014512548
NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH.............................. Science Advisory Board to NCTR............. 3014512559
Advisory Committee on Special Studies 3014512560
Relating to the Possible LongTerm Health
Effects of Phenoxy Herbicides and

Contaminants.

The hotline will provide the most recent information available on upcoming advisory committee meetings, guidance for making an oral presentation during the open public hearing portion of a meeting, and procedures on obtaining copies of transcripts of advisory committee meetings. Because the hotline will communicate the most current information available about any particular advisory committee meeting, this system will provide interested parties with timely and equal access to such information. The hotline should also conserve agency resources by reducing the current volume of inquiries individual FDA offices and employees must handle concerning advisory committee schedules and procedures.

This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

Dated: December 10, 2003.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 0331157 Filed 121703; 8:45 am]
BILLING CODE 416001S

FOR FURTHER INFORMATION CONTACT Theresa L. Green, Committee Management Officer (HF4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 3018271220.